. 2020 Mar;21(3):743–748. doi: 10.31557/APJCP.2020.21.3.743
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Figure 4.
DFS in CD56+ vs. CD56- AML Patients (P = 0.047).